Politics, Policy & Law

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">Money in your pocket</h1><h2 class="title-bottom webtitle">Why the Trump administration wants to put Medicare Part D rebates in patients&#x2019; pockets</h2><div class="byline">Steve Usdin, Washington Editor</div><div class="date"></div></div></div></div>

Biotechnology Innovation Organization

Centers for Medicare & Medicaid Services

Pharmaceutical Research and Manufacturers of America (PhRMA)

U.S. Department of Health & Human Services

Money in your pocket

The Trump administration’s proposal to pass Part D rebates benefits drug companies, hurts PBMs and plan sponsors, and could be popular with seniors.

Why the Trump administration wants to put Medicare Part D rebates in patients’ pockets

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Distillery

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

China Healthcare Summit

Bio€quity Europe

The BioCentury Show

Events

My Workspace

Company Overview

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Trial

Subscribe

Advertising & Sponsorship

Career Opportunities

Customer Resource Center

Contact

Home

<br/><br/><center><span style="font-size:1.75rem;font-weight:500;">Access this Article</span></center>